GalNAc-T6 was reported to induce EMT-like changes by mediating MUC1 glycosylation in breast cancer [34, 35], and promote EMT in prostate cancer cells treated by transforming growth factor-beta [36]. The gene discussed is MUC1; the disease is prostate cancer.